Global Blood Grouping Reagents Market Size, Share & Forecast 2033

The blood grouping reagents market refers to the global commercial market for chemical and biological substances used to determine blood types and compatibility for transfusions, organ transplants, and prenatal screening. The market includes reagents that consist of antisera, monoclonal antibodies, and molecular probes which scientists use for serological testing and genotyping analysis together with their associated automated systems, consumable materials, and diagnostic testing equipment. The market creates its main opportunities from technological advancements which include automated blood typing analyzers, high throughput screening systems, molecular genotyping technology, and point of care testing solutions because these innovations enhance testing precision while decreasing laboratory processing durations and enabling remote medical service provision.
Governments establish regulatory frameworks and standards for reagent quality and safety which government agencies use to control blood safety programs and public healthcare initiatives use to promote advanced diagnostic technologies through their funding programs. Supportive policies aimed at improving blood donation systems and enhancing laboratory capabilities also help drive market growth. For instance, in August 2025, the WHO reports that India collected 14.6 million blood units during the 2024-2025 period while total global blood collection reached 118.5 million units each year. The process of blood typing and cross-matching for each donated blood unit requires the use of ABO and Rh reagents which results in continuous and substantial needs for blood grouping reagents.